ES416311A1 - Un procedimiento de preparacion de esteres dialquilaminoal-quilicos del acido 2-(6-metoxi-2-naftil) propionico. - Google Patents

Un procedimiento de preparacion de esteres dialquilaminoal-quilicos del acido 2-(6-metoxi-2-naftil) propionico.

Info

Publication number
ES416311A1
ES416311A1 ES416311A ES416311A ES416311A1 ES 416311 A1 ES416311 A1 ES 416311A1 ES 416311 A ES416311 A ES 416311A ES 416311 A ES416311 A ES 416311A ES 416311 A1 ES416311 A1 ES 416311A1
Authority
ES
Spain
Prior art keywords
naphthyl
methoxy
formula
propionic
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES416311A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Palo Alto LLC
Original Assignee
Roche Palo Alto LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Palo Alto LLC filed Critical Roche Palo Alto LLC
Publication of ES416311A1 publication Critical patent/ES416311A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/14—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES416311A 1972-06-27 1973-06-26 Un procedimiento de preparacion de esteres dialquilaminoal-quilicos del acido 2-(6-metoxi-2-naftil) propionico. Expired ES416311A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26664072A 1972-06-27 1972-06-27

Publications (1)

Publication Number Publication Date
ES416311A1 true ES416311A1 (es) 1976-05-16

Family

ID=23015387

Family Applications (1)

Application Number Title Priority Date Filing Date
ES416311A Expired ES416311A1 (es) 1972-06-27 1973-06-26 Un procedimiento de preparacion de esteres dialquilaminoal-quilicos del acido 2-(6-metoxi-2-naftil) propionico.

Country Status (13)

Country Link
JP (1) JPS5438097B2 (es)
AT (1) AT323145B (es)
AU (1) AU472375B2 (es)
BE (1) BE801440A (es)
CA (1) CA1012159A (es)
CH (1) CH581605A5 (es)
DE (1) DE2331665C2 (es)
ES (1) ES416311A1 (es)
FR (1) FR2190451B1 (es)
GB (1) GB1377316A (es)
IL (1) IL42472A (es)
NL (1) NL175910C (es)
ZA (1) ZA733992B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA882957B (en) * 1987-04-27 1989-12-27 Syntex Pharma Int Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal anti-inflammatory drugs
JP5424880B2 (ja) * 2006-08-15 2014-02-26 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚透過率を有するアリール−及びヘテロアリールプロピオン酸の正荷電水溶性プロドラッグ
KR101366296B1 (ko) * 2012-03-07 2014-02-21 주식회사 포스코 내화재 축조 방법
JP6290947B2 (ja) * 2016-02-05 2018-03-07 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚透過率を有するアリール−及びヘテロアリールプロピオン酸の正荷電水溶性プロドラッグ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE328272B (es) * 1963-05-02 1970-09-14 Parke Davis & Co
ZA701191B (en) * 1969-03-24 1971-09-29 Syntex Corp 2-(6-substituted-2'-naphthyl)acetic acid esters and process for producing same

Also Published As

Publication number Publication date
NL175910B (nl) 1984-08-16
GB1377316A (en) 1974-12-11
CA1012159A (en) 1977-06-14
JPS5438097B2 (es) 1979-11-19
IL42472A (en) 1977-01-31
IL42472A0 (en) 1973-08-29
NL175910C (nl) 1985-01-16
DE2331665C2 (de) 1983-04-21
FR2190451B1 (es) 1976-12-31
CH581605A5 (es) 1976-11-15
JPS504053A (es) 1975-01-16
BE801440A (fr) 1973-12-26
DE2331665A1 (de) 1974-01-17
NL7308876A (es) 1974-01-02
FR2190451A1 (es) 1974-02-01
AU472375B2 (en) 1976-05-20
ZA733992B (en) 1975-01-29
AU5690373A (en) 1974-12-19
AT323145B (de) 1975-06-25

Similar Documents

Publication Publication Date Title
ES413639A1 (es) Un procedimiento para la preparacion de un compuesto deri- vado de dopamina.
ES456279A1 (es) Un procedimiento para preparar compuestos de cetofosfonato.
ES416311A1 (es) Un procedimiento de preparacion de esteres dialquilaminoal-quilicos del acido 2-(6-metoxi-2-naftil) propionico.
ES404744A1 (es) Un procedimiento para producir derivados de cefalosporina.
ES448594A1 (es) Un procedimiento para preparar compuestos diarilhidroxibuti-lamina.
ES405643A1 (es) Procedimiento para la preparacion de nuevos acidos 4 - (4 -bifenilil) - 4 - hidroxi - butiricos, sus esteres o lacto- nas.
DE2964850D1 (en) Thienylbenzoic-acid derivatives, process for their production, and pharmaceutical preparations containing these compounds
ES385774A1 (es) Procedimiento para la preparacion de nuevas 2-(5-nitro-2- furil)-tieno (3,2-d) pirimidinas.
ES325827A1 (es) Procedimiento para producir compuestos de 2-fenoxi-2-fenilacetamida.
ES441257A1 (es) Procedimiento para preparar aminocicloles.
ES417883A1 (es) Procedimiento para la preparacion de derivados de bifenilo.
ES406131A1 (es) Procedimiento para la preparacion de acidos 4-(4-bifeni- lil)-butiricos y sus esteres.
ES420666A1 (es) Procedimiento para preparar derivados de acidos (1-metil-5-nitro-2-imidazolil)tioalcanoicos.
ES399223A1 (es) Un procedimiento de preparacion de compuestos pirrolidino- na.
ES360858A1 (es) Procedimiento para la preparacion de nuevos derivados de tiazepina.
ES366533A1 (es) Procedimiento para la preparacion de nuevos derivados de 1,2-oxazinicos.
ES410418A1 (es) Un procedimiento para la preparacion de nuevos derivados deacidos xanton-2-carboxilicos.
ES414340A1 (es) Procedimiento de preparacion de derivados de la n-(m-tri- fluormetiltio-fenil-)-piperazina.
ES411184A1 (es) Procedimiento para preparar derivados de penicilinas y ce- falosporinas.
JPS51136684A (en) Process for preparing 5-((2-alkylamino-1-hydroxy) alkyl carbostyril de rivatives
JPS51125281A (en) A process for preparing indazole derivatives
ES444634A2 (es) Procedimiento para la preparacion de derivados de isoindoli-na.
ES313971A1 (es) Procedimiento para la preparacion de nuevos derivados de imidazol.
ES437312A1 (es) Procedimiento para preparar acidos pirimidin-4-il-indol-3- ilaceticos.
ES454239A1 (es) Procedimiento para la obtencion de nuevos derivados de 3,5- pirazolidindiona.